Toggle navigation
About
About us
Management Team
Board of Directors
Advisory Board
R&D
Immuno-oncology
Technology
Collaborations
Publications
Posters
Clinical program
Partnering
Investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
National Prospectus 2024
News
Press releases & other news
Subscribe
Contact
post@lytixbiopharma.com
Investors |
Reports & Presentations |
Presentations
Title
PDF
View
Lytix Biopharma's presentation of Phase II clinical results in Basal Cell Carcinoma
×
Lytix Biopharma's presentasjon av fase II resultater i basalcellekarsinom
×
Lytix Biopharma's ESMOposter webinar - October 23rd 2023
×
Lytix Biopharma's presentation at ABGSC Life Science Summit Seminar - May 31st 2023
×
Lytix Biopharma's shareholder meeting - December 5th 2022
×
Lytix Biopharma's CMD - November 22nd 2022
×
Lytix Biopharma's CMD - June 1st 2022
×
Lytix Biopharma's presentation at 'Arctic Securities Biotech' - April 26th 2022
×
Lytix Biopharma's presentation at 'INVESTORDAGENE' - October 20th 2021
×
investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
National Prospectus 2024